Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes

Frontiers in Physiology

Volumn 5, Issue DEC, 2014, Pages

  McLean, Julie B ^a,b   Moylan, Jennifer S ^a,b   Andrade, Francisco H ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cachexia; Electron transport chain; Mitochondria; Oxidants; Skeletal muscle

Indexed keywords

4 AMINO 5 METHYLAMINO 2', 7' DIFLUOROFLUORESCEINDIACETATE; 4 HYDROXYNONENAL; CELL PROTEIN; CYTOCHROME C OXIDASE; DICHLORODIHYDROFLUORESCEIN DIACETATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME METABOLISM; INCUBATION TIME; LEWIS CARCINOMA; LUNG CANCER; MITOCHONDRIAL RESPIRATION; MOUSE; MUSCLE ATROPHY; MYOTUBE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RESPIRATORY CHAIN; WESTERN BLOTTING;

EID: 84922019625     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00503     Document Type: Article

References (54)

1. Andrade, F. H., Reid, M. B., Allen, D. G., and Westerblad, H. (1998). Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse. J. Physiol. 509 (Pt 2), 565-575.
2. Andrade, F. H., Reid, M. B., and Westerblad, H. (2001). Contractile response of skeletal muscle to low peroxide concentrations: myofibrillar calcium sensitivity as a likely target for redox-modulation. FASEB J. 15, 309-311. doi: 10.1096/fj.00-0507fje
3. Antunes, D., Padrao, A. I., Maciel, E., Santinha, D., Oliveira, P., Vitorino, R., et al. (2014). Molecular insights into mitochondrial dysfunction in cancer-related muscle wasting. Biochim. Biophys. Acta 1841, 896-905. doi: 10.1016/j.bbalip.2014.03.004
4. Argiles, J. M., Figueras, M., Ametller, E., Fuster, G., Olivan, M., De Oliveira, C. C., et al. (2008). Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells. Muscle Nerve 37, 190-195. doi: 10.1002/mus.20899
5. Bruton, J. D., Place, N., Yamada, T., Silva, J. P., Andrade, F. H., Dahlstedt, A. J., et al. (2008). Reactive oxygen species and fatigue-induced prolonged low-frequency force depression in skeletal muscle fibres of rats, mice and SOD2 overexpressing mice. J. Physiol. (Lond). 586, 175-184. doi: 10.1113/jphysiol.2007.147470
6. Busquets, S., Almendro, V., Barreiro, E., Figueras, M., Argiles, J. M., and Lopez-Soriano, F. J. (2005). Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia. FEBS Lett. 579, 717-722. doi: 10.1016/j.febslet.2004.12.050
7. Carbo, N., Costelli, P., Busquets, S., Lopez-Soriano, J., Lopez-Soriano, F. J., Baccino, F. M., et al. (2004). Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma. Int. J. Mol. Med. 14, 719-723. doi: 10.3892/ijmm.14.4.719
8. Chen, Z. H., and Niki, E. (2006). 4-hydroxynonenal (4-HNE) has been widely accepted as an inducer of oxidative stress. Is this the whole truth about it or can 4-HNE also exert protective effects? IUBMB Life 58, 372-373. doi: 10.1080/15216540600686896
9. Cho, S., Szeto, H. H., Kim, E., Kim, H., Tolhurst, A. T., and Pinto, J. T. (2007). A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J. Biol. Chem. 282, 4634-4642. doi: 10.1074/jbc. M609388200
10. Constantinou, C., Fontes De Oliveira, C. C., Mintzopoulos, D., Busquets, S., He, J., Kesarwani, M., et al. (2011). Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia. Int. J. Mol. Med. 27, 15-24. doi: 10.3892/ijmm.2010.557
11. Dumas, J. F., Peyta, L., Couet, C., and Servais, S. (2013). Implication of liver cardiolipins in mitochondrial energy metabolism disorder in cancer cachexia. Biochimie 95, 27-32. doi: 10.1016/j.biochi.2012.07.009
12. 2+-activated force in rat skeletal muscle fibers following in vitro and in vivo stimulation. PLoS ONE 7:e35226. doi: 10.1371/journal.pone.0035226
13. Fearon, K., Arends, J., and Baracos, V. (2013). Understanding the mechanisms and treatment options in cancer cachexia. Nat. Rev. Clin. Oncol. 10, 90-99. doi: 10.1038/nrclinonc.2012.209
14. Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., et al. (2011). Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12, 489-495. doi: 10.1016/S1470-2045(10)70218-7
15. Fedorova, M., Kuleva, N., and Hoffmann, R. (2010). Identification, quantification, and functional aspects of skeletal muscle protein-carbonylation in vivo during acute oxidative stress. J. Proteome Res. 9, 2516-2526. doi: 10.1021/pr901182r
16. Fontes-Oliveira, C. C., Busquets, S., Toledo, M., Penna, F., Paz Aylwin, M., Sirisi, S., et al. (2013). Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency? Biochim. Biophys. Acta 1830, 2770-2778. doi: 10.1016/j.bbagen.2012.11.009
17. Gilliam, L. A., Moylan, J. S., Callahan, L. A., Sumandea, M. P., and Reid, M. B. (2011). Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy. Muscle Nerve 43, 94-102. doi: 10.1002/mus.21809
18. Hardin, B. J., Campbell, K. S., Smith, J. D., Arbogast, S., Smith, J., Moylan, J. S., et al. (2008). TNF-alpha acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. J. Appl. Physiol. (1985) 104, 694-699. doi: 10.1152/japplphysiol.00898.2007
19. Irrcher, I., Ljubicic, V., and Hood, D. A. (2009). Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells. Am. J. Physiol. Cell Physiol. 296, C116-C123. doi: 10.1152/ajpcell.00267.2007
20. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J. Clin. 61, 69-90. doi: 10.3322/caac.20107
21. Johns, N., Stephens, N. A., and Fearon, K. C. (2013). Muscle wasting in cancer. Int. J. Biochem. Cell Biol. 45, 2215-2229. doi: 10.1016/j.biocel.2013.05.032
22. Julienne, C. M., Dumas, J. F., Goupille, C., Pinault, M., Berri, C., Collin, A., et al. (2012). Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency. J. Cachexia Sarcopenia Muscle 3, 265-275. doi: 10.1007/s13539-012-0071-9
23. Julienne, C. M., Tardieu, M., Chevalier, S., Pinault, M., Bougnoux, P., Labarthe, F., et al. (2014). Cardiolipin content is involved in liver mitochondrial energy wasting associated with cancer-induced cachexia without the involvement of adenine nucleotide translocase. Biochim. Biophys. Acta 1842, 726-733. doi: 10.1016/j.bbadis.2014.02.003
24. Khamoui, A. V., and Kim, J. S. (2012). Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia. Eur. J. Cancer Care (Engl). 21, 143-157. doi: 10.1111/j.1365-2354.2011.01287.x
25. Lee, J., Giordano, S., and Zhang, J. (2012). Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441, 523-540. doi: 10.1042/BJ20111451
26. Lemire, J., Mailloux, R. J., and Appanna, V. D. (2008). Mitochondrial lactate dehydrogenase is involved in oxidative-energy metabolism in human astrocytoma cells (CCF-STTG1). PLoS ONE 3:e1550. doi: 10.1371/journal.pone.0001550
27. Luo, L., Sun, Z., Zhang, L., Li, X., Dong, Y., and Liu, T. C. (2013). Effects of low-level laser therapy on ROS homeostasis and expression of IGF-1 and TGF-beta1 in skeletal muscle during the repair process. Lasers Med. Sci. 28, 725-734. doi: 10.1007/s10103-012-1133-0
28. Maclellan, J. D., Gerrits, M. F., Gowing, A., Smith, P. J., Wheeler, M. B., and Harper, M. E. (2005). Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells. Diabetes 54, 2343-2350. doi: 10.2337/diabetes.54.8.2343
29. Manczak, M., Mao, P., Calkins, M. J., Cornea, A., Reddy, A. P., Murphy, M. P., et al. (2010). Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J. Alzheimers Dis. 20(Suppl. 2), S609-S631. doi: 10.3233/JAD-2010-100564
30. Merry, T. L., Steinberg, G. R., Lynch, G. S., and McConell, G. K. (2010). Skeletal muscle glucose uptake during contraction is regulated by nitric oxide and ROS independently of AMPK. Am. J. Physiol. Endocrinol. Metab. 298, E577-E585. doi: 10.1152/ajpendo.00239.2009
31. Michaelson, L. P., Iler, C., and Ward, C. W. (2013). ROS and RNS signaling in skeletal muscle: critical signals and therapeutic targets. Annu. Rev. Nurs. Res. 31, 367-387. doi: 10.1891/0739-6686.31.367
32. Moylan, J. S., Smith, J. D., Wolf Horrell, E. M., McLean, J. B., Deevska, G. M., Bonnell, M. R., et al. (2014). Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle. Redox Biol. 2, 910-920. doi: 10.1016/j.redox.2014.07.006
33. Powers, S. K., Hudson, M. B., Nelson, W. B., Talbert, E. E., Min, K., Szeto, H. H., et al. (2011). Mitochondria-targeted antioxidants protect against mechanical ventilation-induced diaphragm weakness. Crit. Care Med. 39, 1749-1759. doi: 10.1097/CCM.0b013e3182190b62
34. Prochniewicz, E., Lowe, D. A., Spakowicz, D. J., Higgins, L., O'Conor, K., Thompson, L. V., et al. (2008a). Functional, structural, and chemical changes in myosin associated with hydrogen peroxide treatment of skeletal muscle fibers. Am. J. Physiol. Cell Physiol. 294, C613-C626. doi: 10.1152/ajpcell.00232.2007
35. Prochniewicz, E., Spakowicz, D., and Thomas, D. D. (2008b). Changes in actin structural transitions associated with oxidative inhibition of muscle contraction. Biochemistry 47, 11811-11817. doi: 10.1021/bi801080x
36. (2)(+)]i. J. Mol. Cell. Cardiol. 58, 172-181. doi: 10.1016/j.yjmcc.2012.11.011
37. Puppa, M. J., Gao, S., Narsale, A. A., and Carson, J. A. (2014). Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia. FASEB J. 28, 998-1009. doi: 10.1096/fj.13-240580
38. Reid, M. B. (2008). Free radicals and muscle fatigue: of ROS, canaries, and the IOC. Free Radic. Biol. Med. 44, 169-179. doi: 10.1016/j.freeradbiomed.2007.03.002
39. Reid, M. B., Andrade, F. H., Balke, C. W., and Esser, K. A. (2005). Redox mechanisms of muscle dysfunction in inflammatory disease. Phys. Med. Rehabil. Clin. N. Am. 16, 925-949. doi: 10.1016/j.pmr.2005.08.016
40. Roberts, B. M., Ahn, B., Smuder, A. J., Al-Rajhi, M., Gill, L. C., Beharry, A. W., et al. (2013a). Diaphragm and ventilatory dysfunction during cancer cachexia. FASEB J. 27, 2600-2610. doi: 10.1096/fj.12-222844
41. Roberts, B. M., Frye, G. S., Ahn, B., Ferreira, L. F., and Judge, A. R. (2013b). Cancer cachexia decreases specific force and accelerates fatigue in limb muscle. Biochem. Biophys. Res. Commun. 435, 488-492. doi: 10.1016/j.bbrc.2013.05.018
42. Society, A. C. (2012). Cancer Facts and Figures 2012. Atlanta: American Cancer Society.
43. St-Pierre, J., Buckingham, J. A., Roebuck, S. J., and Brand, M. D. (2002). Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277, 44784-44790. doi: 10.1074/jbc. M207217200
44. Tan, B. H., and Fearon, K. C. (2008). Cachexia: prevalence and impact in medicine. Curr. Opin. Clin. Nutr. Metab. Care 11, 400-407. doi: 10.1097/MCO.0b013e328300ecc1
45. Tisdale, M. J. (2009). Mechanisms of cancer cachexia. Physiol. Rev. 89, 381-410. doi: 10.1152/physrev.00016.2008
46. Toime, L. J., and Brand, M. D. (2010). Uncoupling protein-3 lowers reactive oxygen species production in isolated mitochondria. Free Radic. Biol. Med. 49, 606-611. doi: 10.1016/j.freeradbiomed.2010.05.010
47. Turrens, J. F. (2003). Mitochondrial formation of reactive oxygen species. J. Physiol. (Lond). 552, 335-344. doi: 10.1113/jphysiol.2003.049478
48. Tzika, A. A., Fontes-Oliveira, C. C., Shestov, A. A., Constantinou, C., Psychogios, N., Righi, V., et al. (2013). Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model. Int. J. Oncol. 43, 886-894. doi: 10.3892/ijo.2013.1998
49. Vidal-Puig, A., Solanes, G., Grujic, D., Flier, J. S., and Lowell, B. B. (1997). UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem. Biophys. Res. Commun. 235, 79-82. doi: 10.1006/bbrc.1997.6740
50. Von Haehling, S., Morley, J. E., Coats, A. J., and Anker, S. D. (2010). Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J. Cachexia Sarcopenia Muscle 1, 7-8. doi: 10.1007/s13539-010-0003-5
51. Wang, X., Pickrell, A. M., Zimmers, T. A., and Moraes, C. T. (2012). Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexia. PLoS ONE 7:e33426. doi: 10.1371/journal.pone.0033426
52. White, J. P., Puppa, M. J., Sato, S., Gao, S., Price, R. L., Baynes, J. W., et al. (2012). IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse. Skelet. Muscle 2, 14. doi: 10.1186/2044-5040-2-14
53. Whiteman, M., Spencer, J. P., Szeto, H. H., and Armstrong, J. S. (2008). Do mitochondriotropic antioxidants prevent chlorinative stress-induced mitochondrial and cellular injury? Antioxid. Redox Signal. 10, 641-650. doi: 10.1089/ars.2007.1879
54. Yaffe, D., and Saxel, O. (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727.